Cardiovascular risk evaluation in the treatment of Hodgkin lymphoma-are we on the road to individualized planning?
Strahlentherapie und Onkologie, 2023-03, Vol.199 (3), p.333-336
[Peer Reviewed Journal]
EISSN: 1439-099X ;DOI: 10.1007/s00066-023-02051-3 ;PMID: 36749383
Full text available